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Objective(s): We have previously shown that type II endoleak size is a predictor of aneurysm growth after aortic
endografting. To better understand this observation, we investigated the influence of endoleak size on pressure
transmitted to the aneurysm wall and its distribution within the aneurysm sac.
Methods: In an ex vivo model, an artificial aneurysm sac was incorporated within a mock circulation comprised of rubber
tubing and a pulsatile pump. Three strain-gauge pressure transducers were placed in the aneurysm wall at different
locations, including the site of maximum aneurysm diameter. The aneurysm was filled with either human aneurysm
thrombus or dough that mimicked thrombus and simulated type II endoleaks of varying volumes (1 to 10 mL) were
created. Aneurysm wall pressure (AWP) measurements were recorded at mean arterial pressures (MAPs) of 60, 80, and
100 mm Hg. Correlation coefficients (r) and analysis of variance were used to assess the relationship between endoleak
volume and AWP.
Results: Increasing endoleak volume ’3 cm3 resulted in proportionally increased AWP at all levels of MAP and at all sites,
with highest pressures recorded at the site of the maximum aneurysm diameter (r  0.83 when MAP  100 mm Hg;
r  0.85 when MAP  80 mm Hg; r  0.88 when MAP  60 mm Hg; P < .001). AWP plateaued when the endoleak
volume was >3 cm3. Pressure distribution within the sac was not uniform. Although the difference was within 10%,
statistically significant higher AWPs were observed at the site of maximum aneurysm diameter (P <.001). AWP also
correlated with MAP.
Conclusions: Increasing type II endoleak volume results in proportionally higher AWP, which is greatest at the site of
maximum aneurysm diameter. This study confirms the clinical observation that type II endoleak volume and MAP may
be important predictors of aneurysm expansion. (J Vasc Surg 2005;41:657-63.)
Clinical Relevance: Our experimental model of a type II endoleak revealed that endoleak size is a significant factor that
influences the magnitude of pressure transmission into the aneurysm wall. Increasing volume of the endoleak nidus was
associated with proportionally higher aneurysm sac pressures. This mechanismmay, in fact, account for the increased risk
of aneurysm expansion observed in our clinical experience, thereby suggesting the need for more aggressive surveillance
and possibly earlier intervention for patients with larger endoleaks.
aPersistent type II endoleaks develop in 5% to 25% of
patients after endovascular aortic aneurysm repair (EVAR)
as a result of retrograde flow into the aneurysm sac from
patent lumbar arteries, the inferior mesenteric artery, and
other collateral aortic branches.1-9 Because type II en-
From the University of Texas Southwestern Medical Center,a Montefiore
Medical Center,b and Orlando Regional Medical Center.c
Competition of interest: none.
Presented at the Eighteenth Annual Meeting of the Eastern Vascular Soci-
ety, Philadelphia, Penn, April 29 - May 2, 2004.
Reprint requests: Takao Ohki, MD, Montefiore Medical Center, 111East
210th Street, Bronx, NY 10467 (e-mail: takohki@msn.com).
0741-5214/$30.00
Copyright © 2005 by The Society for Vascular Surgery.
doi:10.1016/j.jvs.2004.12.047doleaks may lead to aneurysm enlargement, stability, or
shrinkage, and in a few instances rupture, their clinical
significance and management remains controversial.1,2,6,10
It is currently well recognized that type II endoleaks
may produce systemic blood pressures within the aneu-
rysm sac that may result in aneurysm enlargement and
rupture.6,9,11-14
Although it appears that type II endoleaks have a more
benign natural history compared with type I or III en-
doleaks, we along with others believe that persistent type II
endoleaks associated with aneurysm enlargement require
ggressive management.1,2
In a recent study, we investigated the predictors for
aneurysm enlargement in patients with persistent type en-
657
vity.
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or nidus, was the most important predictor of aneurysm
growth, particularly when it was 15 mm. The current
experimental study was designed to better understand this
observation and to assess the influence of endoleak volume
on the pressure transmitted to the aneurysm wall and its
differential distribution within the aneurysm sac as possible
predictors of aneurysm expansion in patients with persis-
tent type II endoleaks.
METHODS
An experimental ex vivo model was constructed by
incorporating an artificial silicone aneurysm sac into an
artificial circulation composed of rubber tubing connected
to a pulsatile pump (Haemonetics, Braintree, Mass) and a
collecting system (Fig 1). Warm, normal saline at 38° C was
used as the circulation fluid. One inflow and one outflow
channel (diameter, 3 mm) were attached to one end of the
artificial aneurysm sac. Systemic pressures were monitored
continuously during each experiment by using an arterial
line connected to a side port located in the tubing proximal
to the aneurysm. Pressures within the circulation model
were regulated by altering the pump rate and adjusting the
outflow diameter.
The aneurysm was filled with human thrombus col-
lected from the aneurysm sac of patients undergoing open
aortic aneurysm repairs and synthetic thrombus with similar
Fig 1. Diagram of the experimental model and artificia
of different volumes were created within the aneurysm s
Proximal (PT), distal (DT) and middle portion (MT) stra
wall at three different sites in relation to the endoleak capressure transmission properties that were measured andequilibrated with the human sac thrombus by using a
standard calibration process.16 Endoleak cavities of varying
volumes (1, 2, 3, 5 and 10 cm3) were created within the sac
contents. The inflow and outflow channels supplied
straight-line flow to the endoleak cavity.
Three strain-gauge pressure transducers (P 4.5;
Konigsberg Instruments, Pasadena, Calif) were implanted
in the aneurysm wall at three different levels of the sac in
relation to the endoleak cavity: proximal, distal and at the
midportion (ie, the site of maximum aneurysm diameter).
Standard calibration of each transducer was performed
before each experiment using a process that has been
previously described.16
Pressure was allowed to equilibrate before aneurysm
wall pressure (AWP) measurements were recorded at 0.1-
second intervals in direct current voltage with a digital
analog data acquisition system (Model 2701; Keithley In-
struments, Cleveland, Ohio). A standard calibration pro-
cess was used to convert strain measurements into AWPs.
One thousand measurements from each transducer were
digitally recorded at MAPs of 60, 80, and 100 mm Hg at
each endoleak volume. The frequency of the pulsatile pump
was adjusted to maintain specific MAPs as indicated, which
were usually obtained at pulse rates of 60 to 90 beats/min.
During the experiments, steady mean pressures were
reached within the circuit over several minutes before AWP
lation pathway used in this study. Endoleak (E) cavities
hich was filled with human and synthetic thrombus (T).
ge pressure transducers were implanted in the aneurysml circu
ac, w
in-gaumeasurements were acquired.
oeffic
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acquisition system into ExceLINX 1A Software (Keithley
Instruments). Pressures were expressed as medians and rang-
es; these were analyzed with the Mann-Whitney U test for
paired comparisons or nonparametric analysis of variance
(Kruskal-Wallis one-way analysis of variance by ranks). Corre-
lation coefficients (r) with logarithmic transformation of the
AWP data were calculated to assess the relationship between
endoleak volume and AWPs. Findings were considered statis-
tically significant if the resulting P value was.05. For statis-
tical analyses, the Statistical Package for the Social Sciences
(SPSS) software for Windows version 11.0 (SPSS, Inc, Chi-
cago, Ill) and MedCalc statistical software version 7.2.0.2
(MedCalc Software, Mariakerke, Belgium) were used.
RESULTS
The median AWP measurements and ranges recorded
by each transducer at the three mean systemic pressures and
at each endoleak volume are shown in Fig 2.
Endoleak volume. Overall, AWP measurements were
significantly lower with the smallest endoleak cavity (en-
doleak volume, 1 cm3) compared with larger endoleak
cavities (P  .001) (Fig 2). Increasing endoleak volume 3
cm3 resulted in proportional higher AWP measurements
recorded at all transducer sites and at all levels of MAP (Fig
Fig 2. Overall, increasing endoleak volumes from 1cm
pressures (median and ranges) at all transducer sites and
mm Hg, and (C) 60 mm Hg with positive correlation c2). Thus, significant positive correlation existed betweenendoleaks volumes from 1 cm3 to 3 cm3 and AWP mea-
surements at the proximal transducer (r 0.77 whenMAP
 100 mm Hg; r  0.76 when MAP  80 mm Hg; r 
0.74 when MAP  60 mm Hg; P  .001), middle trans-
ducer (r 0.83 whenMAP100mmHg; r 0.85, when
MAP 80 mmHg; r 0.88 when MAP 60 mmHg; P
 .001) and distal transducer (r  0.89 when MAP 100
mmHg; r 0.90 whenMAP 80mmHg; r 0.88 when
MAP  60 mm Hg; P  .001). AWP plateaued when the
endoleak volume was 3 cm3 at all levels of MAP and
locations within the aneurysm sac (correlation coefficients
from 0.087 to 0.331).
Pressure distribution. Median AWPs were statisti-
cally significantly different among the three transducers,
although the absolute difference was relatively small
(10%). At a MAP of 100 mm Hg, median AWPs were
83.9 mm Hg at the proximal transducer, 92.3 mm Hg at
the middle transducer, and 82.8 at the distal transducer (P
 .001). For aMAP of 80mmHg, themedian AWPs at the
proximal, middle, and distal transducers were 71.2, 84.7,
and 77.6 mm Hg respectively, whereas for a MAP of 60
mm Hg, the median AWPs were 59.4, 77.4, and 72.4 mm
Hg, respectively (P  .001). Thus, AWPs measured in the
aneurysm sac were unevenly distributed, with significantly
higher pressures recorded at the site of maximum aneurysm
3 cm3 resulted in proportionally higher aneurysm wall
an arterial pressures (MAP) of (A) 100 mm Hg, (B) 80
ients (r) between 0.74 and 0.89 (P .001).3 to
at mediameter at all levels of MAP (P  .001) (Fig 3). Overall,
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DISCUSSION
The findings of our experimental study indicate that
increasing endoleak volume to a certain limit results in
proportionally higher aneurysm wall pressures at all loca-
tions of the aneurysm sac and at different levels of MAP.
Such increased sac pressures associated with larger en-
doleaks may, in fact, be a critical factor for aneurysm
enlargement observed in patients with persistent type II
endoleaks after EVAR.15
Our experimental data thus suggests that larger type II
endoleaks may benefit from closer observation with more
frequent imaging studies, because aneurysm enlargement
may occur. Alternatively, smaller endoleaks may be safely
observed, because they are associated with lower AWPs and
thereby favor aneurysm sac stability or shrinkage.
An equilibration of pressures between the endoleak
cavity and the aneurysm wall with endoleak volumes 3
cm3 may account for the absence of higher AWPs with
larger endoleak sizes. In fact, systemic, endoleak, and an-
eurysm wall pressures were comparable when endoleak
Fig 3. Aneurysm wall pressures (median and ranges) measured in
the aneurysm sac were significantly higher at the site of maximum
aneurysm diameter (mid-portion), compared with the proximal
and distal transducer sites, at all levels of mean arterial pressures
(MAP) (P .001).volumes were 3 cm3, which suggests that beyond a cer-tain endoleak volume, AWPs only correlate with systemic
perfusion pressures of the endoleak cavity.
In a previous study, we sought to determine the pre-
dictors for aneurysm enlargement in patients with persis-
tent type II endoleaks.15 Endoleak size was estimated by
using the maximum diameter of the main endoleak cavity
or nidus obtained from computed tomography (CT) scan
images because endoleak volume data were not available in
all patients.
Univariate and regression analyses identified the maxi-
mum diameter of the endoleak nidus as a significant pre-
dictor for aneurysm enlargement. Moreover, receiver oper-
ating characteristic curve and Cox regression analyses
revealed that a maximum endoleak nidus diameter 15
mm was associated with a tenfold increased risk of aneu-
rysm expansion. Conversely, the maximum diameter of the
endoleak nidus 15 mm was more frequently associated
with stable and shrinking aneurysms, which thus may be
safely observed since the likelihood of subsequent aneu-
rysm enlargement is low even though spontaneous throm-
bosis of the endoleak cavity did not always occur. The
findings of our current experimental study further support
our clinical observations, because the higher AWP recorded
in association with larger endoleaks may, in fact, account
for the increased risk of aneurysm expansion observed in
these patients.
Coil embolization using translumbar approach is our
preferred treatment for patients with persistent type II
endoleaks associated with aneurysm enlargement.2,7,15 Of
interest in our previous study were two patients whose
endoleak channels remained patent after translumbar em-
bolization.15 Their aneurysm sacs revealed no further
growth after endoleak coil embolization was performed.
The size of the endoleak channel decreased significantly
after the embolization procedures, with obliteration of the
nidus as demonstrated by follow-up CT scans. In fact,
endoleak volume as determined by three-dimensional (3D)
CT reconstructions decreased in size 80% in both pa-
tients.
This observation further supports the direct positive
correlation between the size of the endoleak nidus and the
likelihood of aneurysm expansion. Moreover, if this same
phenomenon consistently occurs in other patients, it may
indicate that the need for complete obliteration of the
endoleak channel may not be necessary to prevent further
aneurysm expansion.
Although the importance of the size of the endoleak
cavity or nidus as a significant predictor for aneurysm
enlargement and the occurrence of systemic aneurysm
sac pressures have been supported by the analysis of our
clinical and experimental data, several limitations and
concerns should be considered with regard to our results
and their potential applicability.15 The study used a
limited set of arbitrarily determined endoleak volumes to
assess endoleak size. Although these endoleak volumes
were selected according to data derived from 3D CT
reconstruction studies of patients with persistent type II
endoleaks, an accurate endoleak size associated with a
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aneurysm wall could not be derived from our findings.
Further clinical and imaging studies that allow the deter-
mination of endoleak volume are necessary to assess its
association with aneurysm sac pressures and its influence
on aneurysm expansion.
Other study limitations may be attributed to the use of
a fixed morphologic model of an endoleak cavity, which in
our study consisted of a spherical nidus fed by two side
branches. A fusiform aneurysm sac model was also used.
Although these models may indeed reveal the association
between endoleak size and sac pressure distribution, they
clearly fail to provide all the intrinsic characteristics of such
a relation as most endoleak channels and aneurysm sacs are
complex and irregular.
Moreover, the number of vessels feeding the endoleak
channels was limited to two with the same diameter and
length. From our previous experimental study, however,
we know that aneurysm sac pressures transmitted through a
patent endoleak are not affected by the length or the
diameter of the endoleak channels feeding the main cavity
or nidus of the endoleak.17
Although human aneurysm sac thrombus recovered
from open aneurysmorrhaphy was used in the current
study, only the association between patent endoleak vol-
umes and AWPs was assessed. Endoleak thrombosis may
decrease sac pressures, as suggested by an experimental
study, but the effects of thrombosed endoleak volume on
AWPs remain undetermined.18
The role of endoleak volume has thus far not been
assessed and therefore its clinical significance is un-
known. Moreover, the current reporting standards for
EVAR do not include endoleak volume as an important
characteristic to describe endoleaks.19 Although its clin-
ical utility remains to be elucidated, our current experi-
mental study indicates that endoleak volume should be
determined in future clinical studies to define its role to
predict the risk of aneurysm enlargement in patients with
persistent endoleaks, particularly in those with failed
translumbar embolization of the endoleak cavity. In this
latter situation, the resulting endoleak volume of par-
tially obliterated cavities with coils and other thrombo-
genic materials may be a critical factor to predict future
aneurysm growth.
Finally, our experimental findings need to be correlated
with clinical observations. Determining the relationship
between endoleak volume and aneurysm sac pressures may
be feasible in the near future with the development of new
noninvasive techniques for monitoring aneurysm sac pres-
sure. At present, newly developed wireless pressure sensors
that are placed in the aneurysm sac immediately before
aneurysm exclusion allow continuous noninvasive moni-
toring of aneurysm sac pressures.2 Our research and devel-
opment efforts, as well as other experimental studies, have
made such technology available with the recent human
implantation of such sensors in patients undergoing endo-
vascular aneurysm repair (T. Ohki, personal communica-
tion, April 2004).In conclusion, our experimental data suggest that en-
doleak volume is an important factor that influences the
magnitude of pressure transmission into the aneurysm wall
in the presence of patent endoleak cavities. Increasing
volume of the endoleak nidus is associated with proportion-
ally higher aneurysm sac pressures that might increase the
risk of aneurysm expansion, thereby indicating the need for
more aggressive surveillance and possibly earlier interven-
tion.
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Dr Maciej L. Dryjski (Buffalo, NY). The natural history and
clinical significance of type II endoleak is not clear, as Dr Timaran
stated. In addition, to make things even more complicated, the
recent study from the Cleveland Clinic, as well as the data from
multicenter study presented at this forum yesterday, suggest that
type II endoleak may, in fact, be at least initially affected by factors
such as type of graft used.
In view of this, creation of an ex vivo model to study type II
endoleaks seems to be an extremely challenging task, and I would
like to congratulate the group on succeeding with it. Unfortu-
nately, reviewing the abstract and glancing through the manu-
script, I misunderstood the model. And I now understand that the
aneurysm sac is completely isolated. One of the questions I had is
why would you not use the endograft inside your aneurysm sac?
That would make it maybe more similar to the situation we have in
real life.
My question is, in your experiment, the aneurysm sac remains
the same but the endoleak volume changes. Do you think that a
three-milliliter endoleak in five-centimeter aneurysm has the same
effect on aneurysm wall pressure as three-milliliter endoleak in
ten-centimeter aneurysm? And if not, would it be better to express
the endoleak volume as a percentage of the total aneurysm sac
volume?
Finally, have you applied the results of your experimental work
to your clinical practice? In other words, do you intervene on all
patients with a large type II endoleak without evidence of aneu-
rysm sac growth, assuming that shear stress and subsequent rup-
ture risk is significant?
Dr Carlos H. Timaran. Regarding your questions, the first
one, why we didn’t use a different model using actual endograft.
The reason was that it was very difficult to change the endoleak
volumes using an endograft. We tried to simplify the model and
that was the main reason why we used this model, which allows us
to modify the endoleak volume in a more effective and controlled
manner.
Now, regarding the relationship between endoleak volumes
and aneurysm sac volumes, we think that yes, there is probably
a very important relationship between those two variables. But
for this study, our main concern was to assess the effects of the
endoleak volume. In our clinical practice, we had seen that the
size of the endoleak cavity was a very important factor to predict
enlargement. But unfortunately, we were only assessing the size
of the endoleak cavity using the diameter. And the reason was
that was the only factor that we could measure in all cases. But
probably the relationship between endoleak volume and sac
volume is very, very important, and further studies are needed to
assess that relationship both experimentally and in clinical prac-
tice.
Now, has this changed our clinical practice? Well, I have to
tell you that we were doing this even before we had our data,
both clinical and experimental. Every time we had a big en-
doleak, we thought that it was important to intervene. And the
reason was what we had seen with our patients before. But
again, this was anecdotal. Now, at least, we have data that proves
that what we were doing before, it was actually supported by
some evidence.
Dr John J. Ricotta (Stony Brook, NY). How big was the
aneurysm in your model? In other words, three ccs representedDr Timaran. It was one hundred-twenty ccs, I forgot to
mention that. And I have to say also that the volumes that we chose
were based on the few patients that actually had that parameter
assessed using three-D reconstruction models. We had patients
with endoleak volumes that, you know, range from point five ccs
up to twenty ccs. So that’s the reason why we chose those volumes.
And the one hundred-twenty -cc volume that we use for the sac
was, I have to say, arbitrary.
Dr Ricotta. When you went above three ccs, did you see any
additional . . .
Dr Timaran.No. That’s very important. No. The pressures
tend to plateau above three ccs, all the way up to any range.
We went up to ten ccs and there was no difference after three
ccs.
Dr Mark Levy (Richmond, Va): Two quick questions. The
first is, could you describe a little bit more how you vary the
actual volume of the endoleak? You showed a circuit there on
the slide, but was there a particular reservoir, if you will, that was
almost like a balloon attached within your circuit that you varied
that size?
Dr Timaran. Yes, that’s what we did exactly, we used a small
reservoir.
Dr Levy. And the second question is, although you varied the
mean arterial pressure within your circuit, some folks probably
would think you might want to also vary the DV/DT, if you will,
the pulse pressure inherent in the endoleak. And if you had, for
instance, a very wide pulse pressure, that might be associated with
greater tension on the aneurysm wall and perhaps greater propen-
sity for aneurysm enlargement.
Did you do anything in terms of varying the difference in the
pulsatility in your circuit as opposed to just looking at changes in
mean arterial pressure?
Dr Timaran. Actually, no, the pulse pressure was steady. I
mean, the systolic and diastolic pressures weremaintained stable, in
order to obtain the same mean arterial pressure. So in fact, I guess
when we were changing the mean arterial pressure, we were also
changing the pulse pressure. But we didn’t assess that parameter
specifically.
Dr Levy. So for a mean arterial pressure, for instance, of
sixty or eighty, were you generating that with any particular
static, was there a static pulse pressure, or did you have that vary
as well?
Dr Timaran.No, it was steady. We modified both the systolic
and diastolic to obtain the specific mean arterial pressure.
Dr Levy. I’m going to expand to just one third question.
And that is, likewise there are some thoughts that the location of
the endoleak may actually play a role in terms of aneurysm
expansion. For instance, if you had two lumbar arteries astride
each other and there was a small endoleak emanating from one
and then being evacuated via the other, that might be less
substantial and clinically relevant than an endoleak that ema-
nated out of an IMA and then circuitously found its way to a
lumbar along the floppy side of a large aneurysm. Have you
done any experiments in terms of locating the endoleak in
different parts of the aneurysm sac and looking at subsequent
tension in the wall?
Dr Timaran. Sure. Actually we have. There is actually a paper
published from our group, that was published two or three years
ago, that showed that the size and the length of the inflow and
outflow channels feeding endoleaks are not that important if the
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And that has to do with endotension. But with patent endoleaks,
we didn’t find any difference. And that’s already been published
before. And actually, a group in the UK also published a similarclick on “Other SVS Meetings.” Now, in our clinical series, we didn’t find any significant differ-
ences regarding the number of vessels filling the endoleak or the type
of vessels filling the endoleak. I agree with you, it makes sense that
thesemay affect the outcomeof a type II endoleak, but that’s notwhatpaper with similar findings. we have seen in the experimental and clinical studies.
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